Fatal pulmonary artery thrombosis in a patient with Behcet's disease, activated protein C resistance and hyperhomocystinemia

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 5, 2000, Pages 421-423

  Misgav, M ^a   Goldberg, Y ^a   Zeltser, D ^a   Eldor, A ^b   Berliner, A S ^a,b  

^a Dept of Int Med 'D' and the A U ^*  (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Behcet's disease; Factor V Leiden; Homocysteine; Thromboembolism; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULATION; ARTICLE; BEHCET DISEASE; CASE REPORT; COR PULMONALE; FATALITY; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MALE; MUTATION; PRIORITY JOURNAL; PULMONARY ARTERY; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; VASCULITIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULANTS; BEHCET SYNDROME; ECHOCARDIOGRAPHY; FACTOR V; FATAL OUTCOME; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MUTATION; PULMONARY ARTERY; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033855263     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200007000-00004     Document Type: Article

References (14)

1. 1. Ehrlich GE. Vasculitis in Behcet's disease. Int Rev Immunol 1997;14: 81-88.
2. 2. Hamuryudan V, Yurdakul S, Moral F, et al. Pulmonary arterial aneurysms in Behcet's syndrome: a report of 24 cases. Br J Rheumatol 1994; 33: 48-51.
3. 3. Kuzu MA, Ozaslan C, Koksoy C, Gurler A, Tuzuner A, Vascular involvement in Behcet's disease: 8-year audit. World J Surg 1994; 18: 948-954.
4. 4. Haznedaroglu IC, Ozcebe O, Celik I, Dundar SV, Kirazli S, Haemostatic markers of procoagulant imbalance in Behcet's disease. Eur J Haematol 1996; 57: 107-108.
5. 5. Hampton KK, Chamberlain MA, Menon DK, Davies JA, Coagulation and fibrinolytic activity in Behcet's disease. Thromb Haemost 1991; 66: 292-294.
6. 6. Tsuyoshi S, Mitsuhiro T, Noboru S, Goro I. Behcet's disease. 1999; 21: 1284-1291.
7. 7. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544.
8. 8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
9. 9. Guermazi S, M'rad S, Lamloum M, et al. Activated Protein C resistance in Behcet's disease. Pathol Biol Paris 1998; 46: 791-795.
10. 10. Lesprit P, Wechsler B, Piette JC, Duboutin LT, Godeau P, Aiach M. Activated protein C resistance caused by factor V Arg506-Gln mutation has no role in thrombotic manifestation of Behcet's disease [Letter]. Ann Rheum Dis 1995; 54: 860.
11. 11. Mammo L, Al-Dallan A, Sultan S, Saour BJ. Association of factor V Leiden with Behcet's Disease. J Rheumatol 1997; 24: 2196-2198.
12. 12. Kosar A, Haznedaroglu IC, Buyukasik Y, Kirazh S, Dundar SV. Activated protein C resistance in Behcet's disease. Rheumatol Int 1998; 17: 249-250.
13. 13. Oner AF, Gurgey A, Gurler A, Mesci L. Factor V Leiden mutation in patients with Behcet's disease. J Rheumatol 1998; 25: 496-498.
14. 14. Gul A, Ozbek U, Inanc M, Konice M, Ozcelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behcet's disease. Br J Rheumatol 1996; 35: 1178-1180.